Phytotherapy Research 2014-05-01

Sensitization of Hep3B hepatoma cells to cisplatin and doxorubicin by corilagin.

Roberto Gambari, Desmond Kwok-Po Hau, Wai-Yeung Wong, Chung-Hin Chui

Index: Phytother Res. 28(5) , 781-3, (2014)

Full Text: HTML

Abstract

The anticancer action of gallotannins is a well-developed topic. We have demonstrated the in vivo antitumour activity of corilagin on Hep3B hepatoma using the xenograft athymic nude mice model. Here, we further report the potential sensitization of Hep3B hepatoma cells to cisplatin and doxorubicin by corilagin. Our results showed that corilagin is able to enhance the cytotoxicity of both cisplatin and doxorubicin on the Hep3B hepatoma cells. We speculate the possible use of corilagin in combination with low dosages of the anticancer chemotherapeutic standard drugs like cisplatin and doxorubicin, with the aim of obtaining an increment in the anticancer effect.Copyright © 2013 John Wiley & Sons, Ltd.

Related Compounds

  • corilagin

Related Articles:

Mechanisms of action of corilagin and tellimagrandin I that remarkably potentiate the activity of beta-lactams against methicillin-resistant Staphylococcus aureus.

2004-01-01

[Microbiol. Immunol. 48(1) , 67-73, (2004)]

Inhibitory effect of the gallotannin corilagin on dextran sulfate sodium-induced murine ulcerative colitis.

2013-11-22

[J. Nat. Prod. 76(11) , 2120-5, (2013)]

Modulation of PAI-1 and tPA activity and thrombolytic effects of corilagin.

2003-12-01

[Planta Med. 69(12) , 1109-12, (2003)]

Corilagin prevents tert-butyl hydroperoxide-induced oxidative stress injury in cultured N9 murine microglia cells.

2011-08-01

[Neurochem. Int. 59(2) , 290-6, (2011)]

Activity of corilagin on post-parasiticide liver fibrosis in Schistosomiasis animal model.

2013-01-01

[Int. J. Immunopathol. Pharmacol. 26(1) , 85-92, (2013)]

More Articles...